Cargando…

Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure

Background. Inflammation plays a crucial role in the progression of chronic heart failure (CHF). Ivabradine is known to reduce the morbidity and mortality of patients with CHF under certain conditions. Beyond the reduction of heart rate, only limited knowledge exists about potential anti-inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rohm, Ilonka, Kretzschmar, Daniel, Pistulli, Rudin, Franz, Marcus, Schulze, P. Christian, Stumpf, Christian, Yilmaz, Atilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086393/ https://www.ncbi.nlm.nih.gov/pubmed/27822484 http://dx.doi.org/10.1155/2016/6949320

Ejemplares similares

Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure
por: Jirak, Peter, et al.
Publicado: (2017)

Characterization of dendritic cells in human and experimental myocarditis
por: Pistulli, Rudin, et al.
Publicado: (2020)

Decrease in Circulating Dendritic Cell Precursors in Patients with Peripheral Artery Disease
por: Kretzschmar, Daniel, et al.
Publicado: (2015)

Analysis of Metabolic Markers in Patients with Chronic Heart Failure before and after LVAD Implantation
por: Hilse, Marion S., et al.
Publicado: (2021)

Decreased Regulatory T Cells in Vulnerable Atherosclerotic Lesions: Imbalance between Pro- and Anti-Inflammatory Cells in Atherosclerosis
por: Rohm, Ilonka, et al.
Publicado: (2015)

Increased Serum Levels of Fetal Tenascin-C Variants in Patients with Pulmonary Hypertension: Novel Biomarkers Reflecting Vascular Remodeling and Right Ventricular Dysfunction?
por: Rohm, Ilonka, et al.
Publicado: (2017)

Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction
por: Schernthaner, Christiana, et al.
Publicado: (2017)

Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018)

Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)

Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
por: Urbanek, Irmina, et al.
Publicado: (2014)

Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis
por: Franke, Jennifer, et al.
Publicado: (2011)

Advances in the management of heart failure: the role of ivabradine
por: Müller-Werdan, Ursula, et al.
Publicado: (2016)

Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
por: Kansal, Anuraag R., et al.
Publicado: (2016)

Ivabradine in Congestive Heart Failure: Patient Selection and Perspectives
por: Sattar, Yasar, et al.
Publicado: (2019)

Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
por: Borer, Jeffrey S., et al.
Publicado: (2012)

Ivabradine Treatment in a Chronic Heart Failure Patient Cohort: Symptom Reduction and Improvement in Quality of Life in Clinical Practice
por: Zugck, Christian, et al.
Publicado: (2014)

Effects of ivabradine hydrochloride combined with trimetazidine on myocardial fibrosis in rats with chronic heart failure
por: Ma, Dongwen, et al.
Publicado: (2019)

Evaluation of ivabradine in left ventricular dyssynchrony and reverse remodeling in patients with chronic heart failure
por: Soylu, Korhan, et al.
Publicado: (2020)

Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020)

Association of ivabradin use with ventricular arrhythmias in heart failure patients
por: Pay, L, et al.
Publicado: (2023)

Ivabradine in patients with heart failure: a systematic literature review
por: Khan, Zeba M., et al.
Publicado: (2023)

Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States
por: Borer, Jeffrey S., et al.
Publicado: (2016)

Ivabradine, coronary artery disease, and heart failure: beyond rhythm control
por: Scicchitano, Pietro, et al.
Publicado: (2014)

Effect of Ivabradine on Endothelial Function in Diastolic and Right Heart Failure Patients
por: Orea-Tejeda, Arturo, et al.
Publicado: (2013)

Nemaline myopathy and heart failure: role of ivabradine; a case report
por: Sarullo, Filippo M, et al.
Publicado: (2015)

Does nitric oxide mediate the effects of ivabradine in patients with heart failure?
por: Mączewski, Michał
Publicado: (2018)

Early administration of ivabradine in patients admitted for acute decompensated heart failure
por: Yang, Teng-Yao, et al.
Publicado: (2022)

Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
por: Nakano, Yusuke, et al.
Publicado: (2021)

The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
por: Griffiths, A, et al.
Publicado: (2014)

Real-World Effectiveness of Ivabradine in Chinese Patients with Chronic Heart Failure: Interim Analysis of the POSITIVE Study
por: Jingmin, Zhou, et al.
Publicado: (2021)

Adding ivabradine to beta-blockers in chronic heart failure: Do not rest without lowering the resting heart rate sufficiently
por: Oomman, Abraham, et al.
Publicado: (2018)

Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta‐analysis of randomized controlled trials
por: Bryan Richard, Sasmita, et al.
Publicado: (2021)

Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine
por: Pereira-Barretto, Antonio Carlos
Publicado: (2016)

The Treatment of Heart Failure-Related Symptoms with Ivabradine in a Case with Peripartum Cardiomyopathy
por: Demir, Serafettin, et al.
Publicado: (2013)

Safety and efficacy of off-label use of ivabradine in patients with acute heart failure
por: Othman, Khaled M. Said, et al.
Publicado: (2019)

Ivabradine in the treatment of systolic heart failure - A systematic review and meta-analysis
por: Anantha Narayanan, Mahesh, et al.
Publicado: (2017)

Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
por: Lee, Ying‐Hsiang, et al.
Publicado: (2021)

The Effect of Ivabradine on Hospitalization of Heart Failure Patients: A Retrospective Cohort Study
por: Al-Balushi, Sara, et al.
Publicado: (2021)

Effect of ivabradine on ventricular arrhythmias in heart failure patients with reduced ejection fraction
por: Pay, Levent, et al.
Publicado: (2023)

Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis
por: Maagaard, Mathias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vfiosrk99kjl5oeghfrg0umgi3